KLA shares fell 21.2% from October 1 to October 30, 2026, against a 1.1% dip for the S&P 500, despite what management called record quarterly revenue. The stock closed at $157.91 on October 30. A 40% gain would lift it to about $220. Trefis's scenario projects a 40.3% rise over three years, or about 12.0% a year before dividends, with revenue growing from $14.5 billion to $21.2 billion and earnings from $5.26 billion to $7.38 billion. Revenue rose 28.9% year on year in the September quarter, up from 7.2% in the December 2025 quarter. KLA guides to $4.7 billion, plus or minus $200 million, for the December quarter. Risks include margin pressure from high memory costs and delayed orders from a couple of customers.

KLA Corporation reported first-quarter fiscal 2027 revenue of $4.14 billion, up from $3.21 billion a year earlier. The figure beat the midpoint of its $4.0 billion guidance, which carried a margin of $200 million either way. Net income was $1.55 billion, or $1.18 per diluted share. Non-GAAP earnings per share were $1.22. Operating cash flow was $1.53 billion, free cash flow $1.34 billion, and capital returns $1.24 billion. Chief executive officer Rick Wallace said process control remains critical to the AI buildout. For the second quarter, KLA expects revenue of $4.7 billion, give or take $200 million. It forecasts GAAP diluted EPS of $1.41, give or take $0.11.

KLA Corporation, which makes chip inspection and measurement tools, is drawing a bullish case built on rising semiconductor complexity and AI-driven demand. Fiscal 2026 revenue rose 11.7% to $13.6 billion, with free cash flow of $3.8 billion and a 35.6% net margin. KLAC shares gained 19.83% over the past 12 months, trailing Applied Materials at 63.07% and Lam Research at 46.65%. Its forward price-to-earnings ratio is 26.95, above the three peers' 21.14, 24.88 and 16.84. Analysts' average price target is about $233.77, with individual targets from $175 to $325. Hedge fund holders rose to 81 from 71. Risks include a chip spending slowdown, US export limits on sales to China, and costly product development.